New York State Teachers Retirement System Sells 6,764 Shares of Humana Inc. (NYSE:HUM)

New York State Teachers Retirement System cut its stake in Humana Inc. (NYSE:HUM) by 6.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 101,201 shares of the insurance provider’s stock after selling 6,764 shares during the quarter. New York State Teachers Retirement System owned 0.08% of Humana worth $25,676,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently made changes to their positions in HUM. AMF Tjanstepension AB grew its position in Humana by 166.8% in the 3rd quarter. AMF Tjanstepension AB now owns 40,051 shares of the insurance provider’s stock worth $12,686,000 after purchasing an additional 25,041 shares during the period. Exchange Traded Concepts LLC purchased a new position in shares of Humana in the 3rd quarter worth $348,000. Bleakley Financial Group LLC grew its holdings in shares of Humana by 14.8% in the third quarter. Bleakley Financial Group LLC now owns 1,841 shares of the insurance provider’s stock worth $583,000 after acquiring an additional 237 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd increased its position in Humana by 1.3% during the third quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,963 shares of the insurance provider’s stock valued at $4,423,000 after acquiring an additional 179 shares during the last quarter. Finally, Stonegate Investment Group LLC lifted its holdings in Humana by 51.4% in the third quarter. Stonegate Investment Group LLC now owns 893 shares of the insurance provider’s stock valued at $283,000 after acquiring an additional 303 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

HUM has been the subject of several research reports. Barclays upped their price target on shares of Humana from $255.00 to $270.00 and gave the company an “equal weight” rating in a research report on Thursday. Truist Financial upped their target price on shares of Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Cantor Fitzgerald reiterated a “neutral” rating and set a $290.00 price target on shares of Humana in a research note on Wednesday. Piper Sandler upped their price objective on Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 15th. Finally, Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and lifted their target price for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Nineteen analysts have rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, Humana presently has a consensus rating of “Hold” and a consensus price target of $293.05.

Insiders Place Their Bets

In related news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction dated Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares of the company’s stock, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.32% of the company’s stock.

Humana Price Performance

NYSE:HUM opened at $253.61 on Friday. The company has a market capitalization of $30.54 billion, a P/E ratio of 22.46, a P/E/G ratio of 2.11 and a beta of 0.56. The business’s 50-day moving average is $271.27 and its 200 day moving average is $294.21. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, beating analysts’ consensus estimates of ($2.26) by $0.10. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, equities research analysts forecast that Humana Inc. will post 16.11 earnings per share for the current fiscal year.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.